Chagas Disease Treatment Market is estimated for 2024 for the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

BURLINGAME, CALIFORNIA , UNITED STATES, June 17, 2024 /EINPresswire.com/ -- Market Overview:

Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan Trypanosoma cruzi. The disease is usually transmitted by triatomine bugs, known commonly as "kissing bugs." It can also be acquired through mother-child transmission, blood transfusions, and organ transplants. Treatment seeks to cure the infection and prevent serious long-term complications.

Market Dynamics:

The Chagas disease treatment market is expected to witness significant growth over the forecast period owing to increasing research funding for development of novel treatments for the disease. For instance, in February 2022, the Foundation for Innovative New Diagnostics (FIND), a global health organization, announced funding of US$ 12 million for developing new diagnostic tools and treatments for Chagas disease, Human African trypanosomiasis, and leishmaniasis. Additionally, rising prevalence of Chagas disease across Latin American countries is also expected to propel demand for effective treatment options. As per WHO, approximately 6-7 million people are estimated to be infected globally, with around 8,000 annual deaths.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/934

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Chagas Disease Treatment companies, key tactics followed by Leading Key Players:

◘ Nortec Quimica SA
◘ Bayer AG
◘ Laboratorio Elea Phoenix SA
◘ Maprimed S.A.
◘ Laboratório Farmacêutico de Pernambuco S/A.

Rising Government Support for Research and Development of Novel Therapeutics

Government agencies and non-profit organizations across the globe have increased funding towards research & development activities focused on finding effective treatment options for Chagas disease. This is because Chagas disease predominantly affects poor populations in Latin America where it is endemic. The World Health Organization has also prioritized Chagas disease and aims to reduce transmission and provide access to diagnosis, treatment and care by 2030. The increasing government focus and support will help drive research into improved therapeutics, easier diagnosis methods and management of chronic Chagas disease. Several initiatives are underway to develop new drug candidates and combination therapies with better efficacy and safety profiles.

High Cost of Treatment Limiting Widespread Access

Effective treatment is still challenging as the currently available medications, Benznidazole and Nifurtimox, can cause serious side effects especially in adult chronic Chagas patients. The lengthy treatment regimen also poses compliance issues. Moreover, both drugs are produced by only one manufacturer each and their production is irregular leading to intermittent availability even in endemic regions. The high cost of treatment makes it unaffordable for most populations in developing nations where the disease is endemic. Governments need to invest resources in improving local production and lowering treatment costs to increase access to diagnosis and therapeutics. Subsidies and financing schemes could help make Chagas disease treatment universally accessible.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/934

Potential for Developing Drugs Targeting Chronic Chagas Disease Management

While the current drugs are effective against acute and early chronic infections, therapeutic options are lacking for managing long term sequelae in chronic Chagas patients. This presents a large unmet need and commercial opportunity. Nearly 30% of chronic Chagas patients develop cardiomyopathy with varying degrees of severity and this causes most morbidity and mortality. Drugs that can prevent or delay the progression of heart damage in chronic Chagas disease may have a huge market. Researchers are exploring immunotherapies and trying to repurpose existing cardioprotective medications that could potentially help manage chronic Chagas disease cardiovascular complications.

Rising Incidences Due to Population Movements and Changing Climate

Changes in climate and increasing immigration from Latin America are contributing to the emergence of Chagas disease in non-endemic regions like United States, Canada, Europe and Western Pacific. Warmer climate is enabling the expansion of transmission zones and different triatomine bug species. Immigration and population movements can also introduce infected people or triatomine bugs to new areas where suitable environmental conditions allow transmission to occur. This warrants public health efforts including research into how climate change may affect Chagas disease epidemiology. Healthcare providers need training to recognize and manage imported cases in non-endemic areas to prevent onward spread.

Growing Adoption of Novel Diagnostic Tools

Early diagnosis is important to provide timely treatment and prevent progression to chronic cardiac form of the disease. However, microscopic examination of fresh blood requires expertise and culture methods have low sensitivity. New serological tests have improved detection and are becoming more widely available. Advanced diagnostic tools in development include rapid diagnostic tests, biomolecular assays and biosensors for point-of-care application. These novel methods allow for easier, earlier and more accurate diagnosis which is crucial for effective case management and control programs. Their adoption in clinical microbiology laboratories as well as in field testing will help address the need for improved diagnosis especially in hard to access areas.

The Study Objectives are:

A comprehensive insight into key players operating in the Chagas Disease Treatment Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2024

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Chagas Disease Treatment market
Chapter 2: Exclusive Summary - the basic information of the Chagas Disease Treatment Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Chagas Disease Treatment
Chapter 4: Presenting the Chagas Disease Treatment Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2024 - 2031
Chapter 6: Evaluating the leading manufacturers of the Chagas Disease Treatment market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2024-2031)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/934

Key Questions Answered:

What is the market size and CAGR of the Chagas Disease Treatment Market during the forecast period?
How is the growing demand impacting the growth of Chagas Disease Treatment Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Chagas Disease Treatment Market?

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.